|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| AFREZZA product sales | |||||
| Collaborations and services | |||||
| Royalties | |||||
| Total revenues | |||||
| Expenses: | |||||
| Cost of goods sold - commercial, excluding amortization of acquired intangible assets | |||||
| Cost of revenue - collaborations and services | |||||
| Research and development | |||||
| Selling | |||||
| General and administrative | |||||
| Selling, general and administrative | |||||
| Amortization of acquired intangible assets | |||||
| Loss (gain) on foreign currency transaction | |||||
| Total expenses | |||||
| Income from operations | |||||
| Other income (expense): | |||||
| Interest income, net | |||||
| Interest expense on liability for sale of future royalties | |||||
| Interest expense | |||||
| Interest expense on financing liability | |||||
| Impairment of available-for-sale investment | |||||
| Gain on bargain purchase | |||||
| Other (expense) income | |||||
| Loss on settlement of debt | |||||
| Total other expense | |||||
| Income before income tax (benefit) expense | |||||
| Income tax (benefit) expense | |||||
| Net Income Loss | |||||
| Net income (loss) per share - basic | |||||
| Weighted average shares used to compute net income (loss) per share - basic | |||||
| Net income (loss) per share - diluted | |||||
| Weighted average shares used to compute net income (loss) per share - diluted | |||||
Loading...